Driving Public Banked Cord Blood Inventory Utilization through Research and Development
Originally recorded Thursday, September 5, 2019 | 12:00 PM CDT
Public umbilical cord blood banks have underutilized resources in both fresh, unused cord blood units (CBU) that don't meet clinical criteria and in clinical CBU that are qualified inventory. In this presentation, Marcie Finney, Executive Director of the Cleveland Cord Blood Center, will discuss ways cord blood banks can optimize inventory by identifying industry drivers, managing acquisition costs, and promoting innovation in research to develop new clinical pathways and additional product pipelines.
This comprehensive webcast covers clinical research approaches in the U.S. and the potential they provide for exponentially expanding public cord blood inventory utilization. Ms. Finney will discuss the substantial potential research and development provides as new products can help drive greater utilization of publicly banked cord blood units, increased utility, and more patient treatments.
View to learn about:
- Optimizing HPC, Cord Blood inventory for use in stem cell transplant
- Developing clinical pathways and product pipelines through research
- Leveraging existing infrastructure, experience, and resources to diversify cord blood utility with a Cell Therapy Incubator Laboratory
Complete the form to view the webcast.
About Share the ScienceShare the Science is a free webinar series designed to bring you powerful presentations by the top experts in cellular therapy. Generously supported by WellSky and Save the Cord Foundation, Share the Science webinars connect you to the world's most innovative and influential scientists, clinical researchers, and experts as they highlight the latest breakthroughs and most promising developments in cellular therapy.
Learn more about Save the Cord Foundation.